PAI Partners Agrees to Acquire Majority Stake in Amplitude Surgical
July 30, 2020
PAI Partners has entered into exclusive negotiations to acquire a majority stake in Amplitude Surgical from Apax Partners and certain managers via an SPV, at a price of €2.15 per share, with a subsequent mandatory public tender offer planned. The transaction preserves existing management involvement and is intended to support Amplitude Surgical's continued international expansion and product development in lower-limb orthopedics.
- Buyers
- PAI Partners
- Targets
- Amplitude Surgical
- Sellers
- Apax Partners, Certain managers of Amplitude Surgical
- Industry
- Medical Devices
- Location
- Auvergne-Rhône-Alpes, France
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Zydus Lifesciences Acquires 85.6% of Amplitude Surgical and Launches Mandatory Tender Offer
March 11, 2025
Medical Devices
Zydus Lifesciences Limited entered into exclusive negotiations to buy a controlling 85.6% stake in Amplitude Surgical, valuing the block at €256.8 million (€6.25 per share), from PAI Partners and certain minority shareholders. After regulatory conditions were fulfilled, the 85.6% stake was completed, and Zydus will file (and then conduct) a simplified mandatory tender offer for the remaining shares at the same €6.25 price, followed by a squeeze-out to delist.
-
PAI Partners and Ardian Agree to Buy Majority Stake in Audiotonix
April 23, 2024
Industrial Services
PAI Partners and Ardian have agreed a deal under which PAI will acquire a majority stake in Audiotonix, becoming the company’s largest shareholder. Ardian will retain a minority stake alongside management.
-
PAI Partners to Acquire Majority Stake in Infra Group
July 6, 2023
Infrastructure
PAI Partners has agreed to acquire a majority stake in Infra Group, a Belgium-headquartered multi-disciplinary network infrastructure services provider. The investment will make PAI the largest shareholder alongside existing investors ICG, Andera Partners and the management team, and will support Infra Group's growth strategy to accelerate expansion organically and via complementary acquisitions.
-
Olympus Partners Acquires PAI Pharma
February 24, 2025
Pharmaceuticals
Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.
-
PAI Partners Acquires 67% Stake in VAMED's European Rehabilitation Business from Fresenius
May 2, 2024
Healthcare Services
PAI Partners will acquire a 67% stake in VAMED's pan‑European rehabilitation business from Fresenius, with Fresenius retaining a 33% stake. The carved‑out business operates 67 clinics across multiple European countries, employs around 10,000 staff and will operate as a standalone rehabilitation platform focused on operational excellence and further investment.
-
PAI Partners Agrees to Acquire Majority Stake in ECF Group
June 14, 2023
Logistics & Distribution
PAI Partners has made a binding offer to acquire a majority stake in ECF Group from French private equity firm Naxicap Partners, with Naxicap remaining a minority investor alongside management. ECF is an omnichannel B2B distributor of equipment, consumables and hygiene products for hospitality and care professionals, headquartered in Grigny, France (~1,750 employees, ~€760m revenue); PAI intends to accelerate growth organically and via acquisitions to consolidate the fragmented market.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.